Immunoliposome for Ewing Sarcoma

Immunoliposomes covered with anti-CD99 mAbs and loaded with small-molecule niraparib may be developed as an adjuvant therapy for advanced EWS. Projected 100 nm IL should provide vascular permeability and tumor tropism; however, extensive preclinical evaluations will also be required regarding hematopoietic and endothelial damage.

Authors

Institutions

Publication Details

Journal
Cancer Genomics & Proteomics
Published
2025-10-28
DOI
https://doi.org/10.21873/cgp.20544
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunoliposome for Ewing Sarcoma

DANIEL E. PANOSYAN, WILLIAM S. PANOSYAN, Joseph L. Lasky, DARON S. YACOUBIAN
Cancer Genomics & Proteomics
Nanoparticle-Based Drug Delivery
article

Immunoliposome for Ewing Sarcoma

DANIEL E. PANOSYAN, WILLIAM S. PANOSYAN, Joseph L. Lasky, DARON S. YACOUBIAN
article en

Abstract

Immunoliposomes covered with anti-CD99 mAbs and loaded with small-molecule niraparib may be developed as an adjuvant therapy for advanced EWS. Projected 100 nm IL should provide vascular permeability and tumor tropism; however, extensive preclinical evaluations will also be required regarding hematopoietic and endothelial damage.

Cancer Genomics & ProteomicsVol. 22(6)
University of California, Los Angeles (US), Cure 4 The Kids Foundation (US)
Openalex Percentile: Top 79%
Nanoparticle-Based Drug Delivery
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.